Epstein-Barr virus associated gastric carcinoma: a report from Iran in the last four decades
- PMID: 17629938
- PMCID: PMC1949397
- DOI: 10.1186/1746-1596-2-25
Epstein-Barr virus associated gastric carcinoma: a report from Iran in the last four decades
Abstract
Background: Epstein-Barr virus has been proved to be associated with many of the human malignancy including gastric carcinoma, one of the most important human malignancies in the world. There has been no study about the presence of EBV in gastric adenocarcinoma in Iran.
Methods: We examined the presence of EBV in 273 formalin fixed paraffin-embedded cases of gastric carcinoma from Cancer institute of Tehran University, from 1969 to 2004. In situ hybridization of EBV-encoded small RNA-1 (EBER-1) was conducted. The strain of positive cases was examined by means of polymerase chain reaction and/or restriction fragment length polymorphism analysis.
Results: We found 9 (3%; 95% CI = 1-5%) EBV positive cases. The gender difference was not statisticaly significant. The proportion of EBV-GC cases in diffuse type was higher than intestinal type (OR = 0.08; 95% CI = 0.002-0.64). EBV-GC cases had no relation with age, location and invasion. Six out of 9 EBV-GC cases were born during the period between 1928 and 1930. All 9 cases were Type A. Prototype F was seen in 6 out of 8 cases. Type "i" was found in 8 cases and type I in 1 case. XhoI+ and XhoI- polymorphism accounted 6 and 3 of the cases, respectively.
Conclusion: Our study is the first to describe the frequency of EBV-GC in Iran and the Middle East, highlighting a very low prevalence with specific clinicopathologic features. The predominance of EBV-GC birth year in a fixed period, suggests that EBV infection or other events at early childhood may be related to the development of EBV-GC later in the life. The predominance of the type "i" and XhoI+ cases are contradictory to other studies in Asia and is similar to what is reported from Latin American countries.
Figures




Similar articles
-
Prevalence and characteristics of Epstein-Barr virus-associated gastric carcinomas in Tunisia.Eur J Gastroenterol Hepatol. 2009 Sep;21(9):1001-7. doi: 10.1097/MEG.0b013e32831f1f53. Eur J Gastroenterol Hepatol. 2009. PMID: 19491698
-
Association of distinctive Epstein-Barr virus variants with gastric carcinoma in Guangzhou, southern China.J Med Virol. 2010 Apr;82(4):658-67. doi: 10.1002/jmv.21731. J Med Virol. 2010. PMID: 20166192
-
Epstein-Barr virus in gastric carcinoma is associated with location in the cardia and with a diffuse histology: a study in one area of Chile.Int J Cancer. 2001 Nov;94(4):527-30. doi: 10.1002/ijc.1510. Int J Cancer. 2001. PMID: 11745439
-
Epstein-Barr virus and gastric carcinoma.Pathol Int. 2010 May;60(5):337-50. doi: 10.1111/j.1440-1827.2010.02533.x. Pathol Int. 2010. PMID: 20518883 Review.
-
Clinicopathological Characteristics of Advanced Epstein-Barr Virus-associated Gastric Cancer Highlighting Aberrant p53 Expression.Anticancer Res. 2022 Oct;42(10):4955-4962. doi: 10.21873/anticanres.16002. Anticancer Res. 2022. PMID: 36191967 Review.
Cited by
-
Helicobacter pylori co-infection with Epstein-Barr virus and the risk of developing gastric adenocarcinoma at an early age: Observational study infectious agents and cancer.Ann Med Surg (Lond). 2021 Jul 31;68:102651. doi: 10.1016/j.amsu.2021.102651. eCollection 2021 Aug. Ann Med Surg (Lond). 2021. PMID: 34386233 Free PMC article.
-
Involvement of HHV-4 (Epstein-Barr Virus) and HHV-5 (Cytomegalovirus) in Inflammatory Bowel Disease and Colorectal Cancer: A Meta-Analysis.Cancers (Basel). 2022 Oct 17;14(20):5085. doi: 10.3390/cancers14205085. Cancers (Basel). 2022. PMID: 36291869 Free PMC article.
-
The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017.Lancet Gastroenterol Hepatol. 2020 Jan;5(1):42-54. doi: 10.1016/S2468-1253(19)30328-0. Epub 2019 Oct 21. Lancet Gastroenterol Hepatol. 2020. PMID: 31648970 Free PMC article.
-
Survival of gastric cancer patients based on pathologic and demographic characteristics in Mazandaran between 2007 and 2013.Gastroenterol Hepatol Bed Bench. 2019 Fall;12(4):315-321. Gastroenterol Hepatol Bed Bench. 2019. PMID: 31749920 Free PMC article.
-
Clinicopathological characteristics of Epstein-Barr virus-positive gastric cancer in Latvia.Eur J Gastroenterol Hepatol. 2019 Nov;31(11):1328-1333. doi: 10.1097/MEG.0000000000001521. Eur J Gastroenterol Hepatol. 2019. PMID: 31569122 Free PMC article.
References
-
- Rickinson AB, Kieff E. Epstein-Barr virus. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, editor. Fields virology. 4. Vol. 2. Philadelphina, Lippincott Williams & Wilkins; 2001. pp. 2575–2628.
-
- IARC Working Group on the Evaluation of Carcinogenic Risks to Humans . Epstein-Barr Virus and Kaposi's sarcoma Herpesvirus: Human Herpesvirus8. Lyon: International Agency for Research on Cancer; 1997. - PubMed
-
- Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J Virol. 1990;64:2309–2318. - PMC - PubMed
-
- Eliopoulos AG, Dawson CW, Mosialos G, Floettmann JE, Rowe M, Armitage RJ, Dawson J, Zapata JM, Kerr DJ, Wakelam MJ, Reed JC, Kieff E, Young LS. CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr virus-encoded LMP1: involvement of TRAF3 as a common mediator. Oncogene. 1996;13:2243–2254. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous